Literature DB >> 29283076

The Value of Electronically Extracted Data for Auditing Outpatient Antimicrobial Prescribing.

Daniel J Livorsi1, Carrie M Linn2, Bruce Alexander1, Brett H Heintz1, Traviss A Tubbs1, Eli N Perencevich1.   

Abstract

OBJECTIVE The optimal approach to auditing outpatient antimicrobial prescribing has not been established. We assessed how different types of electronic data-including prescriptions, patient-visits, and International Classification of Disease, Tenth Revision (ICD-10) codes-could inform automated antimicrobial audits. DESIGN Outpatient visits during 2016 were retrospectively reviewed, including chart abstraction, if an antimicrobial was prescribed (cohort 1) or if the visit was associated with an infection-related ICD-10 code (cohort 2). Findings from cohorts 1 and 2 were compared. SETTING Primary care clinics and the emergency department (ED) at the Iowa City Veterans Affairs Medical Center. RESULTS In cohort 1, we reviewed 2,353 antimicrobial prescriptions across 52 providers. ICD-10 codes had limited sensitivity and positive predictive value (PPV) for validated cases of cystitis and pneumonia (sensitivity, 65.8%, 56.3%, respectively; PPV, 74.4%, 52.5%, respectively). The volume-adjusted antimicrobial prescribing rate was 13.6 per 100 ED visits and 7.5 per 100 primary care visits. In cohort 2, antimicrobials were not indicated in 474 of 851 visits (55.7%). The antimicrobial overtreatment rate was 48.8% for the ED and 59.7% for primary care. At the level of the individual prescriber, there was a positive correlation between a provider's volume-adjusted antimicrobial prescribing rate and the individualized rates of overtreatment in both the ED (r=0.72; P<.01) and the primary care setting (r=0.82; P=0.03). CONCLUSIONS In this single-center study, ICD-10 codes had limited sensitivity and PPV for 2 infections that typically require antimicrobials. Electronically extracted data on a provider's rate of volume-adjusted antimicrobial prescribing correlated with the frequency at which unnecessary antimicrobials were prescribed, but this may have been driven by outlier prescribers. Infect Control Hosp Epidemiol 2018;39:64-70.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29283076     DOI: 10.1017/ice.2017.250

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  5 in total

1.  Using Audit and Feedback to Improve Antimicrobial Prescribing in Emergency Departments: A Multicenter Quasi-Experimental Study in the Veterans Health Administration.

Authors:  Daniel J Livorsi; Rajeshwari Nair; Andrew Dysangco; Andrea Aylward; Bruce Alexander; Matthew W Smith; Sammantha Kouba; Eli N Perencevich
Journal:  Open Forum Infect Dis       Date:  2021-04-14       Impact factor: 4.423

2.  Determination of Antimicrobial Prescribing Practices in an Integrated Health System Emergency Department.

Authors:  Sarah Sartain; John Price; Brooke Bitner; Elizabeth Wolfe; Daniel Ortiz
Journal:  Kans J Med       Date:  2020-06-25

3.  Prevalence of and rationale for antimicrobial prescription during ambulatory care visits in Japan: a prospective, multicentre, cross-sectional study.

Authors:  Junpei Komagamine; Masaki Kobayashi; Takahiro Mori
Journal:  BMJ Open       Date:  2020-08-24       Impact factor: 2.692

4.  Development of an Electronic Algorithm to Identify in Real Time Adults Hospitalized With Suspected Community-Acquired Pneumonia.

Authors:  George Jones; Joe Amoah; Eili Y Klein; Hannah Leeman; Aria Smith; Scott Levin; Aaron M Milstone; Kathryn Dzintars; Sara E Cosgrove; Valeria Fabre
Journal:  Open Forum Infect Dis       Date:  2021-06-02       Impact factor: 3.835

5.  Proxy indicators to estimate appropriateness of antibiotic prescriptions by general practitioners: a proof-of-concept cross-sectional study based on reimbursement data, north-eastern France 2017.

Authors:  Nathalie Thilly; Ouarda Pereira; Jeroen Schouten; Marlies Ejl Hulscher; Céline Pulcini
Journal:  Euro Surveill       Date:  2020-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.